{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Infusion%20Options%2C%20Inc.","name":"Infusion Options, Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-11-19T15:11:58.520Z"},"count":1,"matches":[{"id":"d227388a827329c3","posted_date":"2021-11-09","letter_issue_date":"2021-08-26","company_name":"Infusion Options, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations I","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/d227388a827329c3"}]}